We aim to help those curious about psychedelics find current information on the psychedelic movement.
We are NOT a drug market place.
We do NOT facilitate, nor condone, illegal activity.
We do NOT promote practitioners.
We DO support the spirit of harm reduction through education and community!
LEAD TEAM
Our forum serves as information and networking platform and is spearheaded by forensic psychiatrist Dr. Michael Armbruster, Metro Atlanta Psychiatry, attorney Greg Lake, Esq., a 1st Amendment specialist, and Christopher Sean Grogan, PhD cand. & scientist / mathematical statistician.
Christopher Sean. Grogan, PhD cand., scientist
Psilocybin Information
Johns Hopkins School of Medicine: https://www.hopkinspsychedelic.org/
Palliative Care
Core Benefits in Palliative Settings
Clinical studies, particularly those involving psilocybin, have shown that these therapies can provide rapid and sustained relief for patients with life-threatening illnesses.Clinical studies, particularly those involving psilocybin, have shown that these therapies can provide.
Existential Relief: Research from institutions like Johns Hopkins suggests psychedelics can significantly reduce the fear of death, often through “mystical-type” experiences that foster a sense of interconnectedness and peace.
Sustained Outcomes: Single-dose interventions have shown to maintain antidepressant and anxiolytic effects for months, and in some cases, up to 4.5 years later.
Pain Modulation: Beyond emotional support, psilocybin is being studied for its potential to reduce chronic pain by interacting with serotonin receptors and lowering systemic inflammation.e rapid and sustained relief for patients with life-threatening illnesses.
- Existential Relief: Research from institutions like Johns Hopkins suggests psychedelics can significantly reduce the fear of death, often through “mystical-type” experiences that foster a sense of interconnectedness and peace.
- Sustained Outcomes: Single-dose interventions have shown to maintain antidepressant and anxiolytic effects for months, and in some cases, up to 4.5 years later.
- Pain Modulation: Beyond emotional support, psilocybin is being studied for its potential to reduce chronic pain by interacting with serotonin receptors and lowering systemic inflammation.